Australia’s subscale capabilities in developing new drugs will need smart policy and emerging tech to bridge the decade-long divide between medical research and commercialisation.
That’s according to Dr Craig Rayner, a Monash University Adjunct Professor and founder of AI startup Oktopi, who says crucial skills gaps and even inconsistent language are holding local biotechs back.
Dr Rayner, who has developed drugs around the world and advised governments and the World …
Want to know how this story ends?
Become a subscriber for complete access to all stories on InnovationAus.com and our daily newsletter.
Already a member? Log in here
Do you know more? Contact James Riley via Email.